LymphoSign
Markham
About LymphoSign
LymphoSign is a pharmaceutical company that is focused on the development of drugs for blood cancers. LymphoSign was acquired by Aegera Therapeutics in August 2007. LymphoSign was founded in 2000 and is based in Markham, Canada.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $5.9M
- Funding stage: M&A
- Last round: Series A (Jul 2003)
- Website: lymphosign.com
- Phone: (905) 530-2333
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/lymphosign-3275743 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.